<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 19 Nov 2026 11:07:22 -0500--><rss version="2.0">
    <channel>
        <title>Castle Biosciences, Inc. (CSTL) Press Releases</title>
        <link>https://ir.castlebiosciences.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/castlebiosciences/files/theme/images/logo-sm.png</url>
                <title>Castle Biosciences, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Castle Biosciences Earns 2026 Top Workplaces Awards Recognizing Its People-First Culture]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.castlebiosciences.com/news-events/press-releases/detail/492/castle-biosciences-earns-2026-top-workplaces-awards-recognizing-its-people-first-culture</link>
                <pubDate>Thu, 12 Nov 26 07:00:00 -0500</pubDate>
                <guid>https://ir.castlebiosciences.com/news-events/press-releases/detail/492/castle-biosciences-earns-2026-top-workplaces-awards-recognizing-its-people-first-culture</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Castle Biosciences to Present at the Piper Sandler 38th Annual Healthcare Conference]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.castlebiosciences.com/news-events/press-releases/detail/491/castle-biosciences-to-present-at-the-piper-sandler-38th-annual-healthcare-conference</link>
                <pubDate>Wed, 11 Nov 26 16:30:00 -0500</pubDate>
                <guid>https://ir.castlebiosciences.com/news-events/press-releases/detail/491/castle-biosciences-to-present-at-the-piper-sandler-38th-annual-healthcare-conference</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DecisionDx®-Melanoma Data at SDPA and Dermato-Onco2026 Support the Test's Ability to Refine Risk Assessment Beyond AJCC Staging]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.castlebiosciences.com/news-events/press-releases/detail/490/decisiondx-melanoma-data-at-sdpa-and-dermato-onco2026-support-the-tests-ability-to-refine-risk-assessment-beyond-ajcc-staging</link>
                <pubDate>Wed, 11 Nov 26 07:00:00 -0500</pubDate>
                <guid>https://ir.castlebiosciences.com/news-events/press-releases/detail/490/decisiondx-melanoma-data-at-sdpa-and-dermato-onco2026-support-the-tests-ability-to-refine-risk-assessment-beyond-ajcc-staging</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Castle Biosciences Reports Third Quarter 2026 Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.castlebiosciences.com/news-events/press-releases/detail/489/castle-biosciences-reports-third-quarter-2026-results</link>
                <pubDate>Thu, 05 Nov 26 16:05:00 -0500</pubDate>
                <guid>https://ir.castlebiosciences.com/news-events/press-releases/detail/489/castle-biosciences-reports-third-quarter-2026-results</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Castle Biosciences to Participate in Upcoming Investor Conferences]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.castlebiosciences.com/news-events/press-releases/detail/488/castle-biosciences-to-participate-in-upcoming-investor-conferences</link>
                <pubDate>Wed, 28 Oct 26 07:00:00 -0400</pubDate>
                <guid>https://ir.castlebiosciences.com/news-events/press-releases/detail/488/castle-biosciences-to-participate-in-upcoming-investor-conferences</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Castle Biosciences to Release Third Quarter 2026 Financial Results and Host Webcast on Thursday, Nov. 5, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.castlebiosciences.com/news-events/press-releases/detail/487/castle-biosciences-to-release-third-quarter-2026-financial-results-and-host-webcast-on-thursday-nov-5-2026</link>
                <pubDate>Thu, 15 Oct 26 07:00:00 -0400</pubDate>
                <guid>https://ir.castlebiosciences.com/news-events/press-releases/detail/487/castle-biosciences-to-release-third-quarter-2026-financial-results-and-host-webcast-on-thursday-nov-5-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.castlebiosciences.com/news-events/press-releases/detail/486/acg-2026-data-show-tissuecypher-identifies-elevated-risk-of-progression-beyond-pathology-findings-in-barretts-esophagus</link>
                <pubDate>Mon, 12 Oct 26 16:30:00 -0400</pubDate>
                <guid>https://ir.castlebiosciences.com/news-events/press-releases/detail/486/acg-2026-data-show-tissuecypher-identifies-elevated-risk-of-progression-beyond-pathology-findings-in-barretts-esophagus</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Late-Breaking EADV 2026 Data Support Use of DecisionDx®-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.castlebiosciences.com/news-events/press-releases/detail/485/late-breaking-eadv-2026-data-support-use-of-decisiondx-melanoma-in-slnb-decision-making-and-risk-aligned-post-surgical-management</link>
                <pubDate>Wed, 30 Sep 26 16:30:00 -0400</pubDate>
                <guid>https://ir.castlebiosciences.com/news-events/press-releases/detail/485/late-breaking-eadv-2026-data-support-use-of-decisiondx-melanoma-in-slnb-decision-making-and-risk-aligned-post-surgical-management</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.castlebiosciences.com/news-events/press-releases/detail/484/new-study-shows-that-tissuecypher-changed-management-at-an-expert-surgery-center-in-90-of-patients-with-non-dysplastic-barretts-esophagus</link>
                <pubDate>Mon, 28 Sep 26 07:00:00 -0400</pubDate>
                <guid>https://ir.castlebiosciences.com/news-events/press-releases/detail/484/new-study-shows-that-tissuecypher-changed-management-at-an-expert-surgery-center-in-90-of-patients-with-non-dysplastic-barretts-esophagus</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.castlebiosciences.com/news-events/press-releases/detail/483/new-study-highlights-clinical-need-for-molecular-guidance-in-atopic-dermatitis-treatment-selection-reinforcing-the-value-of-advancead-tx</link>
                <pubDate>Thu, 24 Sep 26 16:30:00 -0400</pubDate>
                <guid>https://ir.castlebiosciences.com/news-events/press-releases/detail/483/new-study-highlights-clinical-need-for-molecular-guidance-in-atopic-dermatitis-treatment-selection-reinforcing-the-value-of-advancead-tx</guid>
                                                                            </item>
            </channel>
</rss>